Alcohol

Alcohol

SCHEMBL3099525

CCO.CCO.NC(O)=S.NC(O)=S

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

MMP1MMP13MMP7MMP8polrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Alcohol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.50
ALDH1A1 P00352 2/20 0.50
ATM Q13315 1/20 0.39
ATR Q13535 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.32
CYP3A4 P08684 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Alcohol SCHEMBL27560437 1.00
Alcohol SCHEMBL8928828 1.00 TSHR (0.50) TSHRALDH1A1ATMATRSMN1; SMN2
Alcohol SCHEMBL10748456 0.96 TSHR (0.46) TSHRALDH1A1ATMATRSMN1; SMN2
Alcohol SCHEMBL28328836 0.96 TSHR (0.46) TSHRALDH1A1ATMATRSMN1; SMN2
Propane SCHEMBL27770056 0.96 TSHR (0.46) TSHRALDH1A1ATMATRSMN1; SMN2
Alcohol SCHEMBL10522243 0.96 TSHR (0.46) TSHRALDH1A1ATMATRSMN1; SMN2
Alcohol SCHEMBL6886787 0.93 TSHR (0.43) TSHRALDH1A1ATMATR
Propane SCHEMBL7026177 0.87 TSHR (0.42) TSHRALDH1A1ATMATRSMN1; SMN2
Propane SCHEMBL11720454 0.87 TSHR (0.42) TSHRALDH1A1ATMATRSMN1; SMN2
Propane SCHEMBL7566447 0.87 TSHR (0.42) TSHRALDH1A1ATMATRSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060240489-A1 Carbodithioate ligands for nanotechnology and biosensing applications NATIONAL SCIENCE FOUNDATION 2006-10-26 US claimed
CN-116547090-A Composition comprising silver nanoplates 巴斯夫欧洲公司 2023-08-04 CN disclosed
CN-116507686-A UV-VIS radiation curable security ink for producing dichroic security features 锡克拜控股有限公司 2023-07-28 CN disclosed
CN-111449077-B Metiram compound bactericide and application thereof 北京联合大学 2021-06-08 CN disclosed
CN-111449077-A Metiram compound bactericide and application thereof 北京联合大学 2020-07-28 CN disclosed
US-7803568-B2 Carbodithioate ligands for nanotechnology and biosensing applications PURDUE RESEARCH FOUNDATION (US) 2010-09-28 US disclosed
US-20080124776-A1 Carbodithioate Ligands For Nanotechnology and Methods of Use NATIONAL SCIENCE FOUNDATION 2008-05-29 US disclosed
US-20060240489-A1 Carbodithioate ligands for nanotechnology and biosensing applications NATIONAL SCIENCE FOUNDATION 2006-10-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060240489-A1 Carbodithioate ligands for nanotechnology and biosensing applications SPR, ICMT, TST TSHR 629/4885ALDH1A1 971/4885ATM 3517/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.